Live Breaking News & Updates on Charles Wykoff

Stay updated with breaking news from Charles wykoff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Gene Therapy Looks Promising for Diabetic Retinopathy

Genes engineered to make an antivascular endothelial growth factor drug showed encouraging results in a phase 2 trial. ....

Soult Ukpyolsi , South Korea , United States , Charles Wykoff , Young Hee Yoon , Asan Medical Center , Blanton Eye Institute , American Society Of Retina Specialists , Houston Methodist Hospital , Medscape Medical , American Society , Retina Specialists , Presented July , Diabetic Retinopathy , Gene Therapy , Biologic Therapy , Vegf Vascular Endothelial Growth Factor , Vascular Endothelial Growth Factor , Ascular Endothelial Growth Factor Vegf , Diabetic Macular Edema , Retinal Disease , Medical Literature , Clinical Research , Clinical Trials , Linical Studies ,

Intravitreal Pegcetacoplan Gets Priority Review for Geographic Atrophy

The FDA has accepted for Priority Review the NDA for intravitreal pegcetacoplan for the treatment of geographic atrophy. ....

United States , Charles Wykoff , Drug Administration , Priority Review , New Drug Application , Retina Consultants , Prescription Drug User Fee Act ,

Brolucizumab Prevails in Treat-and-Extend Trial of Anti-VEGF Therapy for Eye Disease

Longer treatment-free interval with similar vision outcomes versus aflibercept in neovascular AMD ....

Wills Eye Hospital , United States , Tel Aviv , Thomas Jefferson University , Charles Bankhead , Charles Wykoff , Carl Regillo , Sourasky Medical Center , American Society Of Retina Specialists , American Society , Retina Specialists , Anat Loewenstein , Retina Consultants , Medpage Today ,

EyePoint Pharmaceuticals Investor Day to Highlight EYP-1901 and Durasert® Technology Developments and Provide a Financial Update

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

United States , George Elston , Charlesc Wykoff , Charles Wykoff , Carld Regillo , Amy Phillips , Jay Duker , Carl Regillo , Christina Tartaglia , Dario Paggiarino , Equinox Sciences , American Society Of Retinal Surgeons , Thomas Jefferson University , Eyepoint Pharmaceuticals Nasdaq , Green Room Communications , Eyepoint Pharmaceuticals , Eyepoint Pharmaceuticals Inc , Month Safety , Efficacy Data , Trial Evaluating , Hospital Outpatient Rule , Point Pharmaceuticals , Investor Day , Nancy Lurker , Chief Executive Officer , American Society ,

EyePoint Pharmaceuticals Investor Day to Highlight EYP-1901

- Positive 12-Month Safety and Efficacy Data from Phase 1 DAVIO Clinical Trial Evaluating EYP-1901 for the Treatment of Wet AMD announced at ASRS 2022. ....

United States , George Elston , Charlesc Wykoff , Charles Wykoff , Carld Regillo , Amy Phillips , Jay Duker , Carl Regillo , Christina Tartaglia , Dario Paggiarino , Equinox Sciences , American Society Of Retinal Surgeons , Thomas Jefferson University , Eyepoint Pharmaceuticals Nasdaq , Green Room Communications , Eyepoint Pharmaceuticals , Eyepoint Pharmaceuticals Inc , Month Safety , Efficacy Data , Trial Evaluating , Hospital Outpatient Rule , Point Pharmaceuticals , Investor Day , Nancy Lurker , Chief Executive Officer , American Society ,